Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1996
12/12/1996CA2210193A1 Treatment of traveller's diarrhea
12/11/1996EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof
12/11/1996EP0747386A2 Method and antisense oligonucleotides to Interleukin-6 receptor mRNA for inhibiting cellular proliferation
12/11/1996EP0747383A2 Polyamine salts of clavulanic acid
12/11/1996EP0747381A1 Carbapenem derivative
12/11/1996EP0747368A1 Derivatives of monocyclic polyamines, their preparation, and their use as antiviral agents
12/11/1996EP0747363A1 Anti-viral benzimidazole derivatives
12/11/1996EP0747351A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/11/1996EP0747062A2 Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same
12/11/1996EP0747058A1 Acellular vaccine
12/11/1996EP0747051A2 Methods of inducing BEF-1 transcription factor
12/11/1996EP0747047A1 Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent
12/11/1996EP0746624A1 Vector for liver-specific gene therapy
12/11/1996EP0746568A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained
12/11/1996EP0746564A1 4-n-substituted sialic acids and their sialosides
12/11/1996EP0746559A1 Pyrrolo(2,3-d)pyrimidine derivatives as antivirals
12/11/1996EP0746558A1 Phenylalkylamino derivatives of condensed carbapenemes
12/11/1996EP0746557A1 Intracellular signalling mediators
12/11/1996EP0746542A1 Therapeutic benzonitriles
12/11/1996EP0746338A1 Vaccines containing paucilamellar lipid vesicles as immunological adjuvants
12/11/1996EP0746336A1 Prodrugs activated by targeted catalytic proteins
12/11/1996EP0746333A1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv)
12/11/1996EP0746327A1 Acidified nitrite as an antimicrobial agent
12/11/1996EP0746320A1 Hiv protease inhibitors and intermediates
12/11/1996EP0746319A1 Acyclovir derivatives for topical use
12/11/1996EP0746312A1 Guanylhydrazones for treating inflammatory conditions
12/11/1996EP0695305A4 Method of forming oligonucleotides
12/11/1996EP0644887B1 Intermediates in a process for the purification of clavulanic acid
12/11/1996EP0491865B1 Conjugate vaccine for group b streptococcus
12/11/1996EP0437556B1 Substitution analogues of magainin peptides
12/11/1996CN1137400A Method for preparation of drug for curing acute epidemic febrile disease
12/10/1996US5583248 Amino acid derivatives having antiviral activity
12/10/1996US5583226 Chemical intermediates of viricidal nucleotides
12/10/1996US5583221 Antiinflammatory agents, cardiovascular disorders, viricides, fungicides
12/10/1996US5583148 Bis-acyloxymethyl derivatives
12/10/1996US5583132 Hiv infections, aids
12/10/1996US5583131 For treatment or prevention of acquired immune deficiency syndrome, reduced toxicity
12/10/1996US5583125 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents
12/10/1996US5583115 Dialkyltiacumicin compounds
12/10/1996US5583105 Oral pharmaceutical preparation
12/10/1996US5583038 Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins
12/10/1996US5583018 Rapamycin derivative process for its preparation and its use
12/10/1996US5582990 Nucleotide sequence which codes antigen used for detection of lyme disease
12/10/1996CA2114727C Quinoline derivatives as immunostimulants
12/10/1996CA2082270C Anti-viral therapy
12/10/1996CA2023217C Azabicyclo quinolone carboxylic acids
12/10/1996CA1338780C Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
12/08/1996CA2178537A1 Hepatitis gb virus recombinant proteins and uses thereof
12/05/1996WO1996038565A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER
12/05/1996WO1996038548A1 Oxygen activatable formulations for disinfection or sterilization
12/05/1996WO1996038475A1 Helicobacter pylori antigens and vaccine compositions
12/05/1996WO1996038474A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996WO1996038473A2 Antimicrobial cationic peptides
12/05/1996WO1996038461A1 Cleavage of rna using metal complexes
12/05/1996WO1996038460A1 Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038417A1 N-oxides as antibacterial agents
12/05/1996WO1996038174A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
12/05/1996WO1996038171A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1
12/05/1996WO1996038162A1 Method of using lectins for prevention and treatment of skin diseases and disorders
12/05/1996WO1996038150A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996WO1996038147A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
12/05/1996WO1996038144A1 Isothiazolones
12/05/1996WO1996038115A1 Method of using lectins for agglutination and collection of menstrual flow
12/05/1996DE19519822A1 Neue antibakterielle Mittel New antibacterial agents
12/05/1996CA2762921A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2222968A1 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996CA2222797A1 Helicobacter pylori antigens and vaccine compositions
12/05/1996CA2222689A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
12/05/1996CA2222599A1 Antimicrobial cationic peptides
12/05/1996CA2222561A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996CA2221128A1 Hydrolysis and photocleavage of nucleic acid using a metal complex
12/05/1996CA2218253A1 Isothiazolones
12/04/1996EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
12/04/1996EP0745128A1 Hepatitis b virus mutants, reagents and methods for detection
12/04/1996EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development
12/04/1996EP0745083A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
12/04/1996EP0745065A1 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
12/04/1996EP0744955A1 Cyclic heptapeptide anti-inflammatory agent
12/04/1996EP0744948A1 Protease inhibitors
12/04/1996EP0744894A1 Self-assembling multimeric nucleic acid constructs
12/04/1996EP0578644B1 Antibiotic a 40926 ester derivatives
12/04/1996CN1137275A O-aryl O-alkyl O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
12/04/1996CN1137273A Quinolizinone type compounds
12/04/1996CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors
12/04/1996CN1136928A Red sage root use for antivirus of AIDS and hepatitis B
12/04/1996CN1033455C 1-methylcarbapenem derivatives and process for preparation thereof
12/04/1996CN1033451C Alpha-substituted benzenemethanamine derivatives
12/03/1996US5580884 Antimicrobial agents
12/03/1996US5580881 1,2,3,5,6,7,8,8a-Octahydro-5,5,8a-trimethyl-(8aβ)-6-isoquinolineamine derivatives, preparation method therefor and therapeutical use thereof
12/03/1996US5580860 Pharmaceutical composition containing 2-amino-6-chloropurine-9-β-D-2',3'-dideoxyribofuranoxside
12/03/1996US5580767 Some of internucleotide linkages within oligonucleotide are phosphorothioate linkages
12/03/1996US5580739 Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
12/03/1996US5580297 Royal jelly
12/03/1996CA2028140C Novel bacteriocin compositions for use as enhanced broad range
12/03/1996CA1338764C Polyamine derivatives
11/1996
11/28/1996WO1996037624A1 A method for producing influenza hemagglutinin multivalent vaccines